ПУБЛИКАЦИИ ПО BSD‑500 И BSD‑2000
КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ ПО ГИПЕРТЕРМИИ
В представленной ниже таблице приведены результаты клинических исследований по гипертермии, проведённых за последние 30 лет, подтверждающих эффективность применения локальной и регионарной гипертермии в качестве дополнительного метода лечения с лучевой терапией и/или химиотерапией.
Year | Tumor | Author | Title | No. of Patients | Method | System | Journal | Abstract | |
---|---|---|---|---|---|---|---|---|---|
2023 | Pancreatic Cancer | Issels | Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomised clinical trial (2023) | 117 | CT+HT | BSD-2000/3D-MRI | European Journal of Cancer | PR | |
2023 | Not specified | Ademaj | A patterns of care analysis of hyperthermia in combination with radio(chemo)therapy or chemotherapy in European clinical centers (2023) | CT/RCT/RT+HT | BSD-2000/3D-MRI, BSD-500 | Strahlenther Onkol | OT | ||
2023 | Bladder Cancer | Ott | The Emerging Evidence Supporting Integration of Deep Regional Hyperthermia With Chemoradiation in Bladder Cancer (2023) | RCT+HT | BSD-2000/3D-MRI | Semin Radiat Oncol | RV | ||
2022 | Bladder Cancer | Riesterer | Tetramodal therapy with transurethral resection followed by chemoradiation in combination with hyperthermia for muscle-invasive bladder cancer: early results of a multicenter phase IIB study (2022) | 27 | RCT+HT | BSD-2000 3D | IJH | NR | |
2022 | Breast Cancer | De-Colle | Radiotherapy and hyperthermia for breast cancer patients at high risk of recurrence (2022) | 191 | RT+HT | SA-115/BSD-500 | IJH | NR | |
2022 | Rectal Cancer | Schem | Long-Term Outcome in a Phase II Study of Regional Hyperthermia Added to Preoperative Radiochemotherapy in Locally Advanced and Recurrent Rectal Adenocarcinomas (2022) | 49 | RCT+HT | BSD 2000 | Cancers | NR | |
2022 | Not specified | Ademaj | Clinical Evidence for Thermometric Parameters to Guide Hyperthermia Treatment (2022) | Including BSD-2000/3D-MRI, BSD-500 | Cancers | RV | |||
2022 | Cervical Cancer | Gao | Acute and long-term toxicity in patients undergoing induction chemotherapy followed by thermoradiotherapy for advanced cervical cancer (2022) | 105 | CT+RT+HT | BSD-2000 3D | IJH | NR | |
2022 | Breast Cancer | Chichel | Thermal Boost Combined with Interstitial Brachytherapy in Early Breast Cancer Conserving Therapy-Initial Group Long-Term Clinical Results and Late Toxicity (2022) | 32 | RT+HT | BSD-500 | Journal of Personalized Medicine | NR | |
2021 | Prostate Cancer | Beck | Salvage-Radiation Therapy and Regional Hyperthermia for Biochemically Recurrent Prostate Cancer after Radical Prostatectomy (Results of the Planned Interim Analysis) (2021) | 50 | SRT+HT | BSD-2000/3D-MRI | Cancers | NR | |
2021 | Sarcoma | Willner | Neoadjuvant concurrent chemoradiotherapy with and without hyperthermia in retroperitoneal sarcomas: feasibility, efficacy, toxicity, and long-term outcome (2021) | 15 | CRT+HT | BSD-2000/3D-MRI | Strahlenther Onkol | NR | |
2021 | Breast Cancer | Stoetzer | Post-Neoadjuvant Gemcitabine and Cisplatin with Regional Hyperthermia for Patients with Triple-Negative Breast Cancer and Non-pCR after Neoadjuvant Chemotherapy: A Single-Institute Experience (2021) | 53 | CT+HT | BSD 2000 | Breast Care | NR | |
2021 | Pediatric Cancer | Nadobny | Improved patient-specific hyperthermia planning based on parametrized electromagnetic and thermal models for the SIGMA-30 applicator (2021) | CT+HT | BSD 2000/3D | IJH | OT | ||
2021 | Bladder Cancer | Brummelhuis | Long-Term Experience with Radiofrequency-Induced Hyperthermia Combined with Intravesical Chemotherapy for Non-Muscle Invasive Bladder Cancer (2021) | 274 | RF-CHT | Synergo SB-TS 101 | Cancers | NR | |
2021 | Rectal Cancer | Gani | Deep regional hyperthermia with preoperative radiochemotherapy in locally advanced rectal cancer, a prospective phase II trial (2021) | 78 | RT+HT | BSD-2000/3D, BSD-2000 3D/MRI | Radiother Oncol | NR | |
2021 | Soft-tissue sarcoma | Issels | Immune infiltrates in patients with localized high-risk soft tissue sarcoma treated with neoadjuvant chemotherapy without or with regional hyperthermia: A translational research program of the EORTC 62961-ESHO 95 randomised clinical trial (2021) | 109 | CT+HT | BSD-2000/3D, BSD-2000 3D/MRI | European Journal of Cancer | PR | |
2021 | Soft-tissue sarcoma | Lindner | Perioperative chemotherapy and regional hyperthermia for high-risk adult-type soft tissue sarcomas (2021) | CT+HT | BSD-2000/3D, BSD-2000 3D/MRI | European Journal of Cancer | RV | ||
2021 | Rectal cancers | Ott | Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer (2021) | 111 | CT-RT+HT | BSD-2000/3D, BSD-2000 3D/MRI | Cancers | NR | |
2021 | Cervical Cancer | VilasBoas-Ribeiro | MR Thermometry Accuracy and Prospective Imaging-Based Patient Selection in MR-Guided Hyperthermia Treatment for Locally Advanced Cervical Cancer (2021) | 14 | RT+HT | BSD-2000-3D MR | Cancers | OT | |
2020 | Various, e.g., anal, rectal, bladder cancer, and sarcomas | Paulides | Recent technological advancements in radiofrequency and microwave-mediated hyperthermia for enhancing drug delivery (2020) | Regional, superficial, and deep HT | BSD-500, BSD-2000, BSD-2000 3D, BSD-2000 3D/MR, Sigma-30/40/60 | Advanced Drug Delivery Reviews | RV | ||
2020 | General | Datta | Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses (2020) | ReRT+HT, CTRT+HT | Frontiers in Oncology | OT | |||
2020 | Bladder cancer | Dunst | Organerhaltende Therapie des Harnblasenkarzinoms (2020) | RCT+RHT | Strahlenther Onkol | OT | |||
2020 | Breast Cancer | Hader | Differences of the Immune Phenotype of Breast Cancer Cells after Ex Vivo Hyperthermia by Warm-Water or Microwave Radiation in a Closed-Loop System Alone or in Combination with Radiotherapy (2020) | RT+HT | Experimental device / water bath | Cancers | OT | ||
2020 | General | Hader | Immune biological rationales for the design of combined radio- and immunotherapies (2020) | RT+HT | Cancer Immunology, Immunotherapy | RV | |||
2020 | Soft Tissue Sarcoma | Unsoeld | MR Thermometry Data Correlate with Pathological Response for Soft Tissue Sarcoma of the Lower Extremity in a Single Center Analysis of Prospectively Registered Patients (2020) | 11 | R/CT+LHT | BSD-2000 3D/MR | Cancers | NR | |
2020 | Soft Tissue Sarcoma | Bücklein | Ifosfamide, Carboplatin, and Etoposide (ICE) in Combination with Regional Hyperthermia as Salvage Therapy in Patients with Locally Advanced Nonmetastatic and Metastatic Soft-Tissue Sarcoma (2020) | 110 | ICE+RHT | BSD-2000 | Sarcoma | NR | |
2020 | Not specified | Gaipl | Editorial: Radioimmunotherapy-Translational Opportunities and Challenges (2020) | Radioimmunotherapy | Frontiers in Oncology | OT | |||
2020 | Not specified | Adibzadeha | Systematic review of pre-clinical and clinical devices for magnetic resonance-guided radiofrequency hyperthermia (2020) | MR-guided RF HT | BSD-2000-3D-MRI | IJH | RV | ||
2020 | Glioma | Schneider | Radiosensitization of high-grade gliomas through induced hyperthermia: Review of clinical experience and the potential role of MR-guided focused ultrasound (2020) | HT+RT | Radiother Oncol | RV | |||
2020 | Rhabdomyosarcoma | Issels | Systemic antitumor effect by regional hyperthermia combined with low-dose chemotherapy and immunologic correlates in an adolescent patient with rhabdomyosarcoma - a case report (2020) | 1 | CT+HT | BSD-2000 | IJH | OT | |
2019 | Bladder Cancer | Merten | Long‐Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High‐Risk Bladder Cancer (Ta, Tis, T1, T2) (2019) | 79 | RCT+HT | BSD-2000-3D | The Oncologist | NR | |
2019 | Breast Cancer | De-Colle | Hyperthermic chest wall re-irradiation in recurrent breast cancer: a prospective observational study (2019) | 20 | RT+HT | BSD‑500 | Strahlenther Onkol | NR | |
2018 | Soft Tissue Sarcoma | Issels | Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma. The EORTC 62961-ESHO 95 Randomized Clinical Trial (2018) | 341 | CT vs. CT+HT |
BSD‑2000 | JAMA Oncol | PR | |
2018 | Rectal Cancer | Zwirner | External validation of a rectal cancer outcome prediction model with a cohort of patients treated with preoperative radiochemotherapy and deep regional hyperthermia (2018) | 86 | RCT+HT | BSD‑2000 | IJH | NR | |
2014 | Soft Tissue Sarcoma | Angele | Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter study. (2014) | 341 | CT vs. CT+HT |
BSD‑2000 | Ann Surg Oncol | PR | |
2013 | Pancreatic Cancer | Tschoep-Lechner | Gemcitabine and cisplatin combined with regional hyperthermia as second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer. (2013) | 23 | CT+HT | BSD‑2000 | IJH | NR | |
2012 | Cervical Cancer | Westermann | Long-term survival data of triple modality treatment of stage IIB-III-IVA cervical cancer with the combination of radiotherapy, chemotherapy and hyperthermia - an update. (2012) | 68 | RT+HT | BSD‑2000 | IJH | NR | |
2012 | Rectal Cancer | Schroeder | Pathological complete response and sphincter-sparing surgery after neoadjuvant radiochemotherapy with regional hyperthermia for locally advanced rectal cancer compared with radiochemotherapy alone. (2012) | 106 | RCT vs. RCT+HT |
BSD‑2000 | IJH | NR | |
2012 | Cervical Cancer | Heijkoop | Neoadjuvant chemotherapy followed by radiotherapy and concurrent hyperthermia in patients with advanced-stage cervical cancer: a retrospective study (2012) | 43 | RCT+HT | BSD‑2000 | IJH | NR | |
2014 | Cervical Cancer | Heijkoop | Results of concurrent chemotherapy and hyperthermia in patients with recurrent cervical cancer after previous chemoradiation (2014) | 38 | Re-CT+HT | BSD‑2000 | IJH | NR | |
2011 | Pancreatic Cancer | Maluta | Regional hyperthermia combined with chemoradiotherapy in primary or recurrent locally advanced pancreatic cancer : an open-label comparative cohort trial (2011) | 68 | RCT+HT | BSD‑2000 | Strahlenther Onkol | NR | |
2010 | Ovarian Cancer | Fotopoulou | Regional abdominal hyperthermia combined with systemic chemotherapy for the treatment of patients with ovarian cancer relapse: Results of a pilot study (2010) | 36 | CT+HT | BSD‑2000 | IJH | NR | |
2010 | Soft Tissue Sarcoma | Issels | Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. (2010) | 341 | CT vs. CT+HT |
BSD‑2000 | Lancet Oncol | PR | |
2010 | Rectal Cancer | Maluta | Regional hyperthermia added to intensified preoperative chemo-radiation in locally advanced adenocarcinoma of middle and lower rectum (2010) | 76 | RCT+HT | BSD‑2000 | IJH | NR | |
2010 | Soft Tissue Sarcoma | Schlemmer | Thermochemotherapy in patients with extremity high-risk soft tissue sarcomas (HR-STS) (2010) | 47 | RCT+HT | BSD‑2000 | IJH | NR | |
2009 | Bladder Cancer | Wittlinger | Quadrimodal treatment of high-risk T1 and T2 bladder cancer: transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia (2009) | 45 | RCT+HT | BSD‑2000 | Radiother Oncol | NR | |
2009 | Cervical Cancer | Franckena | Radiotherapy and hyperthermia for treatment of primary locally advanced cervix cancer: results in 378 patients (2009) | 378 | RT+HT | BSD‑2000 | IJROBP | NR | |
2008 | Rectal Cancer | Milani | Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer (2008) | 24 | RCT+RHT | BSD‑2000 | Strahlenther Onkol | NR | |
2008 | Cervical Cancer | Franckena | Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial. (2008) | 114 | RT vs. RT+HT |
BSD‑2000 | IJROBP | PR | |
2007 | Prostate Cancer | Maluta | Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: preliminary results of a prospective phase II study (2007) | 144 | CRT+HT | BSD‑2000 | IJH | NR | |
2007 | Vaginal Cancer | Aktas | Concomitant radiotherapy and hyperthermia for primary carcinoma of the vagina: a cohort study. (2007) | 44 | RT+HT | BSD‑2000 | Eur J Obstet | NR | |
2006 | Cervical Cancer | Sreenivasa | Radiochemotherapy combined with regional pelvic hyperthermia induces high response and resectability rates in patients with nonresectable cervical cancer > or =FIGO IIB "bulky". (2006) | 32 | RCT+HT | BSD‑2000 | IJROBP | NR | |
2006 | Ovarian Cancer | Jones | Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma (2006) | 41 | CT+HT | BSD‑2000 | IJH | NR | |
2005 | Cervical Cancer | Westermann | First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma. (2005) | 68 | RCT+HT | BSD‑2000 | Cancer | NR | |
2005 | Ovarian Cancer | Hahn | Prospective assessment of quality of life in ovarian cancer patients receiving whole abdomen hyperthermia and liposomal doxorubicin. (2005) | 32 | CT+HT | BSD‑2000 | IJH | NR | |
2005 | Ovarian Cancer | Alvarez Secord | Phase I/II trial of intravenous Doxil and whole abdomen hyperthermia in patients with refractory ovarian cancer. (2005) | 30 | CT+HT | BSD‑2000 | IJH | NR | |
2005 | Prostate Cancer | Tilly | Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0. (2005) | 22 | RT+HT | BSD‑2000 | Strahlenther Onkol | NR | |
2004 | Rectal Cancer | Hildebrandt | Regional pelvic hyperthermia as an adjunct to chemotherapy (oxaliplatin, folinic acid, 5-fluorouracil) in pre-irradiated patients with locally recurrent rectal cancer: a pilot study. (2004) | 9 | RT+HT | BSD‑2000 | IJH | NR | |
2004 | Soft Tissue Sarcoma | Fiegl | Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults. (2004) | 20 | CT+HT | BSD‑2000 | IJH | NR | |
2003 | Rectal Cancer | Juffermans | Reirradiation and hyperthermia in rectal carcinoma: a retrospective study on palliative effect. (2003) | 54 | RT+HT | BSD‑2000 | Cancer | NR | |
2003 | Cervical Cancer | Jones | A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma. (2003) | 12 | RT+HT | BSD‑2000 | Cancer | NR | |
2003 | Prostate Cancer | Kalapurakal | Efficacy of irradiation and external hyperthermia in locally advanced, hormone-refractory or radiation recurrent prostate cancer: a preliminary report. (2003) | 13 | RT+HT | BSD‑2000 | IJROBP | NR | |
2003 | Cervical Cancer | Van der Zee | The Dutch Deep Hyperthermia Trial: results in cervical cancer (2003) | 114 | RT vs. RT+HT |
BSD‑2000 | IJH | PR | |
2003 | Pediatric Tumors | Wessalowski | An approach for cure: PEI-chemotherapy and regional deep hyperthermia in children and adolescents with unresectable malignant tumors (2003) | 39 | CT+HT | BSD‑2000 | Klin Padiatr | NR | |
2013 | Germ Cell Tumors | Wessalowski | Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study (2013) | 44 | CT+HT | BSD‑2000 | Lancet Oncol | NR | |
2002 | Soft Tissue Sarcoma | Wendtner | Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas. (2002) | 58 | CT+HT | BSD‑2000 | JCO | NR | |
2001 | Soft Tissue Sarcoma | Issels | Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study. (2001) | 59 | CT+HT | BSD‑2000 | Eur J Cancer | NR | |
2001 | Germ Cell Tumors | Schneider | Treatment of recurrent malignant sacrococcygeal germ cell tumors: analysis of 22 patients registered in the German protocols MAKEI 83/86, 89, and 96. (2001) | 22 | CT+HT | BSD‑2000 | JCO | NR | |
2001 | Soft Tissue Sarcoma | Wendtner | Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia. (2001) | 54 | RCT+HT | BSD‑2000 | Eur J Cancer | NR | |
2001 | Prostate Cancer | Kalapurakal | Re-irradiation and external hyperthermia in locally advanced, radiation recurrent, hormone refractory prostate cancer: a preliminary report. (2001) | 3 | RT+HT | BSD‑2000 | Br J Radiol | NR | |
2000 | Rectal Cancer | Anscher | A pilot study of preoperative continuous infusion 5-fluorouracil, external microwave hyperthermia, and external beam radiotherapy for treatment of locally advanced, unresectable, or recurrent rectal cancer. (2000) | 15 | CT+HT | BSD‑2000 | IJROBP | NR | |
2000 | Cervical Cancer | Van der Zee | Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumors: a prospective, randomized, multicentre trial. Dutch Deep Hyperthermia Group (2000) | 114 | RT vs. RT+HT |
BSD‑2000 | Lancet | PR | |
2000 | Rectal Cancer | Rau | Preoperative radiochemotherapy in locally advanced or recurrent rectal cancer: regional radiofrequency hyperthermia correlates with clinical parameters. (2000) | 55 | RCT+HT | BSD‑2000 | IJROBP | NR | |
2000 | Bladder Cancer | Van der Zee | Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumors: a prospective, randomized, multicentre trial. Dutch Deep Hyperthermia Group (2000) | 101 | CT+RT vs. RT+HT |
BSD‑2000 | Lancet | PR | |
2000 | Rectal Cancer | Van der Zee | Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumors: a prospective, randomized, multicentre trial. Dutch Deep Hyperthermia Group (2000) | 143 | RT vs. RT+HT |
BSD‑2000 | Lancet | PR | |
1999 | Soft Tissue Sarcoma | Prosnitz | The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapy. (1999) | 97 | RT+HT | BSD‑2000 | IJROBP | NR | |
1999 | Cervical Cancer | de Wit | A phase I/II study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervix. (1999) | 19 | CT+HT | BSD‑2000 | Br J Radiol | NR | |
1998 | Germ Cell Tumors | Wessalowski | Hyperthermia for the treatment of patients with malignant germ cell tumors: a phase I/II study in ten children and adolescents with recurrent or refractory tumors (1998) | 7 | CT+HT | BSD‑2000 | Cancer | NR | |
1998 | Rectal Cancer | Rau | Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: a phase II clinical trial. (1998) | 37 | RCT+HT | BSD‑2000 | Ann Surg Oncol | NR | |
1997 | Germ Cell Tumors | Wessalowski | Treatment results in children and adolescents with loco-regional recurrences of abdominal germ cell tumors (GCTs): a pilot-study with PEI chemotherapy and regional deep hyperthermia (RHT) in comparison to a matched cohort (1997) | 9 | CT+HT | BSD‑2000 | Klin Padiatr | NR | |
1997 | Prostate Cancer | Anscher | Combined external beam irradiation and external regional hyperthermia for locally advanced adenocarcinoma of the prostate. (1997) | 30 | RT+HT | BSD‑2000 | IJROBP | NR | |
1996 | Deep Tumors | Myerson | A phase I/II study to evaluate radiation therapy and hyperthermia for deep-seated tumours: a report of RTOG 89-08. (1996) | 66 | RT+HT | BSD‑2000 | IJH | NR | |
1994 | Soft Tissue Sarcoma | Scully | Clinical outcome after neoadjuvant thermoradiotherapy in high grade soft tissue sarcomas (1994) | 40 | RT+HT | BSD‑2000 | J Surg Oncol | NR | |
1994 | Head & Neck Tumor | Valdagni | Radical radiation alone versus radical radiation plus microwave hyperthermia for N3 (TNM-UICC) neck nodes: a prospective randomized clinical trial. (1994) | 44 | RT vs. RT+LHT |
BSD‑500 | IJROBP | PR | |
1991 | Prostate Cancer | Kaplan | Secondary external-beam radiotherapy and hyperthermia for local recurrence after 125-iodine implantation in adenocarcinoma of the prostate (1991) | 6 | RT+HT | BSD‑2000 | IJROBP | NR | |
1991 | Genitourinary Cancer | Petrovich | Regional hyperthermia in patients with recurrent genitourinary cancer. (1991) | 53 | RT vs. RT+HT |
BSD‑2000 | Am J Clin Oncol | NR | |
1990 | Soft Tissue Sarcoma | Issels | Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study. (1990) | 40 | CT+HT | BSD‑2000 | JCO | NR | |
2019 | Rectal Cancer | Ott | Chemoradiotherapy with and without deep regional hyperthermia for squamous cell carcinoma of the anus (2019) | 112 | RCT vs RCT + HT |
BSD‑2000 | Strahlenther Onkol | NR | |
2016 | Breast Cancer | Auoragh | Re-irradiation of the chest wall for local breast cancer recurrence : Results of salvage brachytherapy with hyperthermia. (2016) | 18 | Re-RT + IHT | BSD‑500 | Strahlenther Onkol | NR | |
2002 | Head & Neck Tumor | Geiger | Pulsed-dose rate brachytherapy with concomitant chemotherapy and interstitial hyperthermia in patients with recurrent head-and-neck cancer. (2002) | 15 | Re-RT + CT+IHT |
BSD‑500 | Brachytherapy | NR | |
2000 | Soft Tissue Sarcoma | Zschaeck | Neoadjuvant chemotherapy plus radiation versus chemotherapy plus regional hyperthermia in high-grade soft tissue sarcomas: a retrospective comparison. (2000) | 61 | CT+RT vs. CT+HT |
BSD‑2000 | Brachytherapy | NR | |
2019 | Cervical Cancer | Datta | Efficacy and Safety Evaluation of the Various Therapeutic Options in Locally Advanced Cervix Cancer: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials (2019) | 9894 | Various | IJROBP | MA | ||
2016 | Breast Cancer (recurrent) | Datta | Hyperthermia and Radiation Therapy in Locoregional Recurrent Breast Cancers: A Systematic Review and Meta-analysis. (2016) | 627 | Various | IJROBP | MA | ||
2016 | Head & Neck Tumor | Datta | Hyperthermia and radiotherapy in the management of head and neck cancers: A systematic review and meta-analysis. (2016) | 451 | Various | IJH | MA | ||
2017 | Cervical Cancer | Datta | Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: A systematic review and meta-analysis. (2017) | 2445 | Various | Gynecol Oncol | MA | ||
2016 | Cervical Cancer | Datta | Hyperthermia and radiotherapy with or without chemotherapy in locally advanced cervical cancer: a systematic review with conventional and network meta-analyses. (2016) | 807 | Various | IJH | MA | ||
2015 | Summary Review | Cihoric | Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry. (2015) | Various | IJH | RV | |||
2013 | Summary Review | Overgaard | The heat is (still) on--the past and future of hyperthermic radiation oncology. (2013) | Various | Radiother Oncol | RV | |||
2002 | Summary Review | Wust | Hyperthermia in combined treatment of cancer. (2002) | Various | IJH | RV | |||
2016 | Summary Review | Issels | Hallmarks of hyperthermia in driving the future of clinical hyperthermia as targeted therapy: translation into clinical application. (2016) | Various | IJH | RV |
- CHT
- Chemothyperthermia
- HT
- Hyperthermia
- IHT
- Interstitial Hyperthermia
- LHT
- Local Hyperthermia
- RCT
- RadioChemotherapy
- RT
- Radiotherapy